Combate, Geneboy P.
HRN: 28-27-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/12/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/12/2025
12/18/2025
IV
300mg
Q6
Peritonsillar Abscess
Checking Final Appropriateness
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes